Vice-President, Preclinical Development
Dr. Bordeleau is a molecular and cellular biologist by training and has over 17 years of experience in research, preclinical development of cancer therapeutics and proteomics. She holds a PhD in molecular biology from McGill University and completed a postdoctoral fellowship in cell biology at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal. Before joining the Neurenati team, Dr. Bordeleau served for 9 years as Deputy Director of the Molecular Genetics of Stem Cells Research Unit at IRIC under the direction of Dr. Guy Sauvageau, where she contributed to the development of small molecules, therapeutic antibodies and cell therapy-based approaches for hematological cancers.